These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24982035)

  • 1. Measuring the impact of Clostridium difficile Infection with the NAP1 strain on severity and mortality.
    Rao K
    Clin Infect Dis; 2014 Oct; 59(8):1193-4. PubMed ID: 24982035
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial commentary: Host-pathogen interactions in Clostridium difficile infection: it takes two to tango.
    Aronoff DM
    Clin Infect Dis; 2014 May; 58(10):1401-3. PubMed ID: 24604896
    [No Abstract]   [Full Text] [Related]  

  • 3. NAP1 strain type predicts outcomes from Clostridium difficile infection.
    See I; Mu Y; Cohen J; Beldavs ZG; Winston LG; Dumyati G; Holzbauer S; Dunn J; Farley MM; Lyons C; Johnston H; Phipps E; Perlmutter R; Anderson L; Gerding DN; Lessa FC
    Clin Infect Dis; 2014 May; 58(10):1394-400. PubMed ID: 24604900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continued decline in the prevalence of the Clostridioides difficile BI/NAP1/027 strain across the United States Veterans Health Administration.
    Gentry CA; Williams RJ; Campbell D
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115308. PubMed ID: 33626478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of relapse of Clostridium difficile disease with BI/NAP1/027.
    Marsh JW; Arora R; Schlackman JL; Shutt KA; Curry SR; Harrison LH
    J Clin Microbiol; 2012 Dec; 50(12):4078-82. PubMed ID: 23052318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemic ribotypes of Clostridium (now Clostridioides) difficile are likely to be more virulent than non-epidemic ribotypes in animal models.
    Vitucci JC; Pulse M; Tabor-Simecka L; Simecka J
    BMC Microbiol; 2020 Feb; 20(1):27. PubMed ID: 32024477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fourteen-genome comparison identifies DNA markers for severe-disease-associated strains of Clostridium difficile.
    Forgetta V; Oughton MT; Marquis P; Brukner I; Blanchette R; Haub K; Magrini V; Mardis ER; Gerding DN; Loo VG; Miller MA; Mulvey MR; Rupnik M; Dascal A; Dewar K
    J Clin Microbiol; 2011 Jun; 49(6):2230-8. PubMed ID: 21508155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.
    Sirard S; Valiquette L; Fortier LC
    J Clin Microbiol; 2011 Dec; 49(12):4040-6. PubMed ID: 21956985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection.
    Heinlen L; Ballard JD
    Am J Med Sci; 2010 Sep; 340(3):247-52. PubMed ID: 20697257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of Clostridium difficile infection epidemiology.
    Lessa FC; Gould CV; McDonald LC
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S65-70. PubMed ID: 22752867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile infection: a worldwide disease.
    Burke KE; Lamont JT
    Gut Liver; 2014 Jan; 8(1):1-6. PubMed ID: 24516694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
    Petrella LA; Sambol SP; Cheknis A; Nagaro K; Kean Y; Sears PS; Babakhani F; Johnson S; Gerding DN
    Clin Infect Dis; 2012 Aug; 55(3):351-7. PubMed ID: 22523271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.
    Broukhanski G; Low DE; Pillai DR
    J Clin Microbiol; 2011 May; 49(5):1983-6. PubMed ID: 21411590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin.
    Figueroa I; Johnson S; Sambol SP; Goldstein EJ; Citron DM; Gerding DN
    Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S104-9. PubMed ID: 22752857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for standardization of Clostridium difficile typing methods.
    Huber CA; Foster NF; Riley TV; Paterson DL
    J Clin Microbiol; 2013 Sep; 51(9):2810-4. PubMed ID: 23784128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
    Labbé AC; Poirier L; Maccannell D; Louie T; Savoie M; Béliveau C; Laverdière M; Pépin J
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3180-7. PubMed ID: 18573937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile: the increasingly difficult pathogen.
    Pop-Vicas A; Neill MA
    Crit Care; 2008; 12(1):114. PubMed ID: 18304376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
    Hemminger J; Balada-Llasat JM; Raczkowski M; Buckosh M; Pancholi P
    Infection; 2011 Aug; 39(4):371-3. PubMed ID: 21509425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypervirulent strains of Clostridium difficile.
    Cookson B
    Postgrad Med J; 2007 May; 83(979):291-5. PubMed ID: 17488855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and emerging sources of Clostridioides difficile infection.
    Turner NA; Smith BA; Lewis SS
    PLoS Pathog; 2019 Dec; 15(12):e1008125. PubMed ID: 31856240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.